|
ISRCTN
|
ISRCTN23325295
|
|
ClinicalTrials.gov identifier
|
|
|
Public title
|
Disease manifestation and disease management in chronic heart failure
|
|
Scientific title
|
A standardised multidisciplinary disease management programme improves mortality and morbidity in patients with systolic heart failure - the Interdisciplinary Network for Heart failure (INH) Study
|
|
Acronym
|
INH-Study
|
|
Serial number at source
|
N/A
|
|
Study hypothesis
|
Network care when compared to usual care reduces mortality and hospitalisation (combined primary end point) and/or improves quality of life 6 months after randomisation.
Please note that extensive amendments have been made to this ISRCTN record as of 20/08/2009. They include the following:
1. Scientific title was added
2. Target number of participants was changed from 700 to 1,000
3. Trial end date was updated from 31/12/2006 to 30/09/2009
All other changes are recorded in the relevant fields.
|
|
Lay summary
|
Not provided at time of registration
|
|
Ethics approval
|
Ethics Committee of the Faculty of Mecidine, University of Würzburg (Ethik-Kommission der Medizinischen Fakultät der Universität Würzburg), approved on 09 January 2004 (ref: 130/03)
|
|
Study design
|
Two-arm parallel-group randomised intervention study
|
|
Countries of recruitment
|
Germany
|
|
Disease/condition/study domain
|
Chronic heart failure
|
|
Participants - inclusion criteria
|
1. Age >18 years
2. Written informed consent
3. Heart failure documented by reduced left ventricular ejection fraction (<=40%) during hospitalisation and clinical signs/symptoms of heart failure (peripheral edema, pulmonary edema, rales, pulmonary congestion confirmed by X-ray, elevated jugular venous pressure, exertional dyspnea)
|
|
Participants - exclusion criteria
|
1. Insufficient mental or verbal or physical ability to participate in a telephone assisted monitoring and education program
2. No telephone line installed
|
|
Anticipated start date
|
01/03/2004
|
|
Anticipated end date
|
30/09/2009
|
|
Status of trial
|
Completed |
|
Patient information material
|
Not available in web format, please use the contact details below to request a patient information sheet
|
|
Target number of participants
|
1,000
|
|
Interventions
|
This is a 2-arm parallel group randomised intervention study. Patients are randomised 1:1 into network care and usual care. Intensified patient care and management (i.e. network care) is characterised by:
1. Telephone based symptom-oriented patient monitoring following a predefined algorithm depending on the severity of the condition
2. Telephone based patient-oriented education and training regarding heart failure manifestation, diet, psychological dimensions
|
|
Primary outcome measure(s)
|
Current primary outcome measure as of 20/08/2009:
1. Death of any cause or hospitalisation of any cause (combined endpoint)
Previous primary outcome measures:
1. Death of any cause or hospitalisation of any cause (combined endpoint)
2. Quality of life
|
|
Secondary outcome measure(s)
|
Current secondary outcome measures as of 20/08/2009:
1. Components of composite primary endpoint
2. Cardiovascular death
3. Cardiovascular hospitalisation
4. Proportion of patients treated in adherence with current heart failure treatment guidelines
2. Quality of life
5. Cost-effectiveness analyses
Previous secondary outcome measures:
1. Components of composite primary endpoint
2. Cardiovascular death
3. Cardiovascular hospitalisation
4. Proportion of patients treated in adherence with current heart failure treatment guidelines
5. Cost-effectiveness analyses
|
|
Sources of funding
|
1. German Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]).
2. Head Organisation of non-private health insurances (Spitzenverbände der gesetzlichen Krankenkassen).
Added on 24/08/2009: Additional funding was received from the German Competence Network Heart Failure for the 'extended INH-Study' in 2006 and 2009.
|
|
Trial website
|
|
|
Publications
|
1. 2009 publication (in German) on the interventions used in this study in http://www.ncbi.nlm.nih.gov/pubmed/19340758
2. 2012 results in http://www.ncbi.nlm.nih.gov/pubmed/21956192
|
|
Contact name
|
Prof
Christiane E
Angermann
|
|
Address
|
Klinikstrasse 6-8
|
|
City/town
|
Wuerzburg
|
|
Zip/Postcode
|
97070
|
|
Country
|
Germany
|
|
Tel
|
+49 (0)931 201 70460
|
|
Fax
|
+49 (0)931 201 71240
|
|
Email
|
angermann_c@klinik.uni-wuerzburg.de
|
|
Sponsor
|
University of Wuerzburg (Germany)
|
|
Address
|
Sanderring 2
|
|
City/town
|
Wuerzburg
|
|
Zip/Postcode
|
97070
|
|
Country
|
Germany
|
|
Tel
|
+49 (0)931 31 2231
|
|
Fax
|
+49 (0)931 31 2100
|
|
Email
|
kanzler@zv.uni-wuerzburg.de
|
|
Date applied
|
21/09/2005
|
|
Last edited
|
18/04/2012
|
|
Date ISRCTN assigned
|
30/11/2005
|